Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017.

MLA

Pottle, Alison, et al. “Lipoprotein Apheresis Efficacy, Challenges and Outcomes: A Descriptive Analysis from the UK Lipoprotein Apheresis Registry, 1989-2017.” Atherosclerosis, vol. 290, Nov. 2019, pp. 44–51. EBSCOhost, https://doi.org/10.1016/j.atherosclerosis.2019.09.006.

APA

Pottle, A., Thompson, G., Barbir, M., Bayly, G., Cegla, J., Cramb, R., Dawson, T., Eatough, R., Kale, V., Neuwirth, C., Nicholson, K., Payne, J., Scott, J., Soran, H., Walji, S., Watkins, S., Weedon, H., & Nath Datta, D. B. (2019). Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017. Atherosclerosis, 290, 44–51. https://doi.org/10.1016/j.atherosclerosis.2019.09.006

Chicago

Pottle, Alison, Gilbert Thompson, Mahmoud Barbir, Graham Bayly, Jaimini Cegla, Robert Cramb, Tina Dawson, et al. 2019. “Lipoprotein Apheresis Efficacy, Challenges and Outcomes: A Descriptive Analysis from the UK Lipoprotein Apheresis Registry, 1989-2017.” Atherosclerosis 290 (November): 44–51. doi:10.1016/j.atherosclerosis.2019.09.006.